Gina Kennedy

ScandiBio Therapeutics → Company → Gina Kennedy

14

Feb

Date February 14, 2018

Long established fact that a reader will be distracted by the readable content of a page when looking at it’s layout. The point of using Lorem Ipsum

Author SCANDIBIO

Search for:

Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Parkinson’s disease patientsAugust 5, 2021
Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Alzheimer’s disease patientsJuly 20, 2021
The results of a phase II and III clinical trials about the treatment of COVID-19 patients with CMAs have been published at Advanced ScienceJune 29, 2021
Phase 3 human clinical trial shows that metabolic activators accelerates recovery in COVID-19 patientsFebruary 24, 2021
Phase 2 human clinical trial shows that metabolic activators reduces liver fat in NAFLD patientsFebruary 4, 2021